Back to top
Mabtas T 500 mg Injection
Mabtas T 500 mg Injection

Mabtas T 500 mg Injection

Mabtas T 500 mg Injection Specification

  • Origin of Medicine
  • Allopathic
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Salt Composition
  • Rituximab
  • Drug Type
  • Biologic / Monoclonal Antibody
  • Ingredients
  • Rituximab 500 mg
  • Physical Form
  • Injection
  • Function
  • Treatment of certain types of cancer and autoimmune conditions (e.g. non-Hodgkins lymphoma chronic lymphocytic leukemia and rheumatoid arthritis)
  • Recommended For
  • Patients diagnosed with conditions responsive to Rituximab such as cancer or autoimmune disorders
  • Dosage
  • 500 mg
  • Dosage Guidelines
  • Administered intravenously under the supervision of a healthcare professional
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store in a refrigerator (2C to 8C). Do not freeze. Keep away from light.
 
 

About Mabtas T 500 mg Injection



Mabtas T 500 mg Injection is a biologic monoclonal antibody formulated as an injection containing Rituximab 500 mg. This allopathic medicine is primarily used for the treatment of certain types of cancer and autoimmune conditions, including non-Hodgkins lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It is administered intravenously under the supervision of a healthcare professional. Each box contains 1 vial of Rituximab suitable for adult patients. The recommended storage instructions advise keeping it refrigerated between 2C to 8C, protected from light to maintain efficacy.

FAQs of Mabtas T 500 mg Injection:


Q: How is Mabtas T 500 mg Injection administered?

A: Mabtas T 500 mg Injection is administered intravenously by a healthcare professional.

Q: What are the conditions Mabtas T 500 mg Injection is recommended for?

A: It is recommended for patients diagnosed with conditions responsive to Rituximab, such as cancer or autoimmune disorders.

Q: Are there any specific storage instructions for Mabtas T 500 mg Injection?

A: Yes, it should be stored in a refrigerator between 2C to 8C and protected from light.

Q: What is the dosage of Rituximab in Mabtas T 500 mg Injection?

A: Each injection contains 500 mg of Rituximab.

Q: Is Mabtas T 500 mg Injection suitable for children?

A: No, it is suitable for adults only.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Astronex 1 mg Tablet

Astronex 1 mg Tablet

Recommended For : Postmenopausal women with hormone receptorpositive breast cancer

Origin of Medicine : Synthetic

Dosage Guidelines : Take as prescribed by a healthcare professional preferably at the same time each day with or without food

Drug Type : Tablet, Other

Physical Form : Other, Tablet

Function : Other, Used in the treatment of breast cancer

Doxobin 50 mg Injection

Doxobin 50 mg Injection

Recommended For : Treatment of various cancers including breast cancer leukemia and lymphoma

Origin of Medicine : Synthetic

Dosage Guidelines : Administer as prescribed by the oncologist. Typically given intravenously under medical supervision.

Drug Type : Injection

Physical Form : Liquid

Function : Other, Anticancer medication

Celomide 5 mg Capsule

Celomide 5 mg Capsule

Recommended For : Patients with cancer who require immunomodulatory treatment

Origin of Medicine : Allopathic

Dosage Guidelines : As prescribed by a healthcare professional; typically taken once daily with water

Drug Type : Antineoplastic Agent, Other

Physical Form : Other, Capsule

Function : Used for the treatment of certain cancers such as multiple myeloma and myelodysplastic syndromes, Other

Azadine 100 mg Injection

Azadine 100 mg Injection

Recommended For : Patients with myelodysplastic syndromes

Origin of Medicine : Allopathic

Dosage Guidelines : Administered as an injection under the supervision of a healthcare provider

Drug Type : Injection

Physical Form : Liquid

Function : Used to treat myelodysplastic syndromes (MDS) and certain other bloodrelated cancers, Other